BioShares: Subsidiary Approved to Produce Emergency Vaccines for Foot-and-Mouth Disease

People’s Finance News, April 7. April 7 announcement by Bio shares (600201). The company stated that on April 7, its wholly owned subsidiary, Bao Ling Company, was approved to produce an emergency-immunization foot-and-mouth disease vaccine for South Africa type 1 unit antigen and a foot-and-mouth disease vaccine for South Africa type 1 inactivated vaccine (Re-SAT1/2026 strain). Foot-and-mouth disease type 1 in South Africa is a category of acute, highly contagious disease characterized by rapid onset, fast transmission, and serious harm caused by the foot-and-mouth disease type 1 virus in South Africa. It mainly infects animals such as cattle, sheep, and pigs. After the South Africa type 1 foot-and-mouth disease vaccine is approved for temporary production, the company will actively cooperate with the national disease prevention and control policies, accelerate the advancement of emergency immunization work, strictly organize production in accordance with relevant requirements, ensure vaccine quality, and safeguard the healthy and stable development of the livestock industry.